| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9259cfa966fe620251340a003f5d6125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91205 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2009-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daf721e8f6d8d4fa42ca4e658764b9b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c44d840de55e93dde7444f7c8bd4809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_197d377b9ce2e500bb8714f30a8139d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_535a6f6aa477988ff7854594d69a8f17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22f8c29106a27ae111537abe1c597edf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6684e80028ed3a8ff6f3c8e360dd11f |
| publicationDate |
2010-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2235537-A2 |
| titleOfInvention |
Identification of predictive markers of response to dasatinib in human colon cancer |
| abstract |
Methods and compositions are provided useful in the diagnosis, treatment and management of cancers wherein cancer cells express certain polynucleotides and/or polypeptides that are differentially expressed in colon cancer subtypes that are sensitive to therapy with abl kinase inhibitors and src kinase inhibitors. In particular, PTK-7, PLK-2 and PLK-3 could be identified as markers for determining the responsiveness of cancer to dasatinib. |
| priorityDate |
2008-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |